TNC and breast cancer: A further mediator of cell motility is tenascin C. By binding to either integrin αvβ1 or αvβ6, recombinant tenascin C induced a change in the morphology of the breast cancer cell line MCF-7 to a more mesenchymal phenotype (Figure 2) (81).